The company states that unlimited support is available seven days per week, though customer experiences with response times vary significantly
Jabby supports all major GLP-1 medications including Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), and other GLP-1 receptor agonists prescribed for diabetes management and weight loss
Cardiovascular risk reduction Wegovy injection and tablets are both approved in adults with heart disease and obesity or overweight to reduce the risk of serious heart problems, like heart attack, stroke or heart-related death
Effectiveness in Weight Loss Clinical studies suggest Rybelsus may lead to a marginally higher weight loss compared to Jardiance, although individual results can vary
The 2024 structural paper by the Wang group provides a side-by-side comparison with semaglutide and tirzepatide bound to their respective receptors